Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2 ragimovaasia@gmail.com
Список исп. литературыСкрыть список 1. Bodén R, Lundgren M, Brandt L et al. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ 2012; 345: e7085. DOI: 10.1136/bmj.e7085 2. Brockington I. Emotional Rejection of the Infant: Status of the Concept. Psychopathology 2016; 49: 247–60. DOI: 10.1159/ 000448334 3. Brockington I, Butterworth R, Glangeaud-Freudenthal N. An international position paper on mother-infant (perinatal) mental health, with guidelines for clinical practice. Arch Womens Ment Health 2017; 20 (1): 113–20. DOI: 10.1007/s00737-016-0684-7 4. Brockington I. Maternal rejection of the young child: present status of the clinical syndrome. Psychopathology 2011; 44 (5): 329–36. DOI: 10.1159/000325058 5. Brockington IF, Aucamp HM, Fraser C. Severe disorders of the mother-infant relationship: definitions and frequency. Arch Womens Ment Health 2006; 9: 243–52. 6. Brockington IF, Fraser C, Wilson D. The Postpartum Bonding Questionnaire: a validation. Arch Womens Ment Health 2006; 9 (5): 233–42. 7. Brockington IF, Margison FR, Schofield E, Knight RJ The clinical picture of the depressed form of puerperal psychosis. J Affect Dis 1988; 15 (1): 29–37. 8. Burt VK, Suri R, Altshuler L et al. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001; 158: 1001–9. 9. Carroll BT, Goforth HW, Kennedy JC, Dueño OR. Mania due to general medical conditions: frequency, treatment, and cost. Int J Psychiatry Med 1996; 26 (1): 5–13. 10. Coppola D, Russo LJ, Kwarta RF Jr et al. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf 2007; 30 (3): 247–64. 11. Dalton K. Progesterone prophylaxis used successfully in postnatal depression. Practitioner1985; 229: 507–8. 12. Diav-Citrin O, Shechtman S, Ornoy S et al. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry 2005; 66 (3): 317–22. PMID: 15766297. 13. Eberhard-Gran M, Eskild A, Opjordsmoen S. Use of Psychotropic Medications in Treating Mood Disorders During Lactation: Practical Recommendations. CNS Drugs 2006; 20: 187–98. 14. Epperson CN, Wisner KL, Yamamoto B. Gonadal steroids in the treatment of mood disorders. Psychosomatic Med 1999; 61 (5): 676–97. 15. Esser G, Dinter R, Jörg M et al. Bedeutung und Determinanten der frühen Mutter-Kind-Interaktion. Z Psychosom Med Psychoanal 1993; 39: 246–64. 16. Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: A review of the evidence. Pediatrics 2009; 124: e547–e556. 17. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 2004; 38 (7–8): 1265–71. PMID: 15150376. 18. Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 2000; 20 (4): 399–403. PMID: 10917399. 19. Gregoire AJ, Kumar R, Everitt B et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 347: 930–3. 20. Habermann F, Fritzsche J, Fuhlbrück F et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol 2013; 33 (4): 453–62. DOI: 10.1097/JCP. 0b013e318295fe12 21. Hays P, Douglass A. A comparison of puerperal psychosis and the schizophreniform variant of manic-depression. Acta Psychiatr Scand 1984; 69 (3): 177–81. 22. Hays P. Taxonomic map of the schizophrenias, with special reference to puerperal psychosis. Br Med J 1978; 2 (6139): 755–7. 23. Howard L, Goss C, Leese M et al. The psychosocial outcome of pregnancy in women with psychotic disorders. Schizophrenia Res 2004; 71: 49–60. 24. Kerstis B, Aarts C, Tillman C et al Association between parental depressive symptoms and impaired bonding with the infant. Arch Womens Ment Health 2016; 19: 87–94 25. Kozyrskyj AL, Mai XM, McGrath P et al. Continued exposure to maternal distress in early life is associated with an increased risk of childhood asthma. Am J Respir Crit Care Med 2008; 177: 142. 26. Kumar R. "Anybody’s child": severe disorders of mother-to-infant bonding. Br J Psychiatry 1997; 171: 175–81. 27. Larson EW, Richelson E. Organic causes of mania. Mayo Clin Proc 1988; 63 (9): 906–12. 28. Lawrie TA, Hofmeyr GJ, de Jager M et al. A double-blind randomized placebo controlled trial of postnatal norethisteroneenanthate: the effect on postnatal depression and serum hormones. Br J Obstet Gynaecol 1998; 105: 1082–90. 29. Margison FR. Assessment of mother-infant interaction and attachment: an overview; in Cox JL, Kumar R, Margison FR, Downey LJ (eds): Puerperal Mental Illness. Southampton, Duphar Medical Relations, 1986; p. 29–33. 30. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30 (5): 985–92. 31. Newham JJ, Thomas SH, MacRitchie K et al. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008; 192 (5): 333–7. DOI: 10.1192/bjp.bp.107.041541. Erratumin: Br J Psychiatry 2008; 192 (6): 477. 32. Newport DJ, Calamaras MR, DeVane CL et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.Am J Psychiatry 2007; 164 (8): 1214–20. 33. O’Hara MW, McCabe JE. Postpartum depression: current status and future directions. Annu Rev Clin Psychol 2013; 9: 379–407. PubMed: 23394227. 34. Oberlander TF, Misri S, Fitzgerald CE et al. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65 (2): 230–7. 35. Pitt B. Atypical depression following childbirth. Br J Psychiatry 1968; 114: 1325–35. 36. Reis M, Källén B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008; 28 (3): 279–88. DOI: 10.1097/JCP.0b013e318172b8d5 37. Rochon-Terry G et al. Hospitalizations and emergency department visits for psychiatric illness during and after pregnancy among women with schizophrenia. J Clin Psychiatry 2016. 38. Sanna G, Bertolaccini ML, Cuadrado MJ et al. Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach. Curr Pharm Des 2008; 14 (13): 1261–9. 40. Sit DK, Perel JM, Helsel JC, Wisner KL. Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry 2008; 69 (4): 652–8. 41. Slone D, Siskind V, Heinonen OP et al. Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 1977; 128 (5): 486–8. PMID: 879206. 42. Szabó A, Brockington I. Auto-Caesarean section: a review of 22 cases. Arch Womens Ment Health 2014; 17 (1): 79–83. DOI: 10.1007/s00737-013-0398-z 43. Tomson T, Battino D, Bonizzoni E et al. EURAP study group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10 (7): 609–17. DOI: 10.1016/S1474-4422 (11)70107-7 44. Uddenberg N, Englesson I. Prognosis of postpartum mental disturbance: a prospective study of primiparous women and their 4,5½ year old children. Acta Psychiatr Scand 1978; 58: 201–12. 45. Veiby G, Daltveit AK, Schjølberg S et al. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 2013; 54 (8): 1462–72. DOI: 10.1111/epi.12226 46. Viguera AC, Newport DJ, Ritchie J et al. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry 2007; 164 (2): 342–5. 47. Weissman A, Levy B, Hartz A et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004; 161: 1066–78. 48. Yonkers KA, Lin H, Howell HB et al. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry 2008; 69 (4): 659–65. 49. Zegers B, Andriessen P. Maternal lithium therapy and neonatal morbidity. Eur J Pediatr 2003; 162 (5): 348–9. 50. Молохов А.Н. Очерки гинекологической психиатрии. Кишенев: Картя Молдовеняскэ, 1962. / Molohov A.N. Ocherki ginekologicheskoj psihiatrii. Kishenev: Kartya Moldovenyaske, 1962. [in Russian] 51. Смулевич А.Б. Психические расстройства в клинической практике. М.: МЕДпресс-информ, 2011. / Smulevich A.B. Psihicheskie rasstrojstva v klinicheskoj praktike. M.: MEDpress-inform, 2011. [in Russian]